3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
16
Phase 1/2
3
Phase 1
3
Phase 3
2
Phase 2/3
2
Phase NA
1
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
7
Sarcoma
1
Conditions
Sarcoma, Ewing
1
Patient Compliance
1
Pathologic Complete Response
1
Osteosarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Chondrosarcoma
1
Bone Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
13
Ifosfamide
12
Doxorubicin
12
Blood Specimen Collection
12
Radiotherapy
11
Methotrexate
10
fludarabine phosphate
9
Surgical Procedures, Operative
9
Radiosurgery
9
Cyclophosphamide
9
Surveys and Questionnaires
8
Cyclosporine
8
Proton Therapy
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
7
Mycophenolic Acid
6
Melphalan
6
Whole-Body Irradiation
5
Standard of Care
5
Filgrastim
5
Etoposide
5
Early Intervention, Educational
5
Carboplatin
5
Biopsy
5
Antilymphocyte Serum
5
Vincristine
4
Temozolomide
4
Sunitinib
4
Radiation Dose Hypofractionation
4
Mesna
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
regorafenib
×
Sarcoma
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled